|
End-of-day quote
Shenzhen S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 7.410 CNY | -0.40% |
|
-3.89% | -14.24% |
| Market Cap | 3.78B 568M 509M 469M 425M 794M 54.07B 807M 5.6B 2.23B 28.3B 2.13B 2.09B 89.62B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.3B 496M 444M 410M 371M 693M 47.22B 705M 4.89B 1.95B 24.72B 1.86B 1.82B 78.28B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.12% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | -0.40% | ||
| 1 week | -3.89% | ||
| Current month | -10.29% | ||
| 1 month | -9.41% | ||
| 3 months | -3.89% | ||
| 6 months | -9.85% | ||
| Current year | -14.24% |
| 1 week | 7.37 | 7.79 | |
| 1 month | 7.37 | 8.48 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 06/04/2022 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 02/12/2022 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 08/05/2014 |
Ai Guo Shi
CHM | Chairman | 62 | 30/06/2017 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 12/04/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | -3.89% | -17.21% | -28.95% | 568M | ||
| +4.02% | +11.82% | +68.62% | +151.72% | 1,224B | ||
| +1.22% | +5.94% | +47.84% | +90.09% | 662B | ||
| +1.80% | +3.25% | +29.24% | +107.86% | 514B | ||
| +0.49% | +3.27% | +54.26% | +67.30% | 388B | ||
| +2.61% | +3.82% | +74.80% | +46.88% | 361B | ||
| +1.66% | +5.17% | +36.14% | +59.07% | 302B | ||
| +6.73% | +8.53% | +10.94% | +36.21% | 271B | ||
| +2.66% | +7.87% | +62.27% | +80.03% | 249B | ||
| +3.81% | +10.83% | +46.01% | +122.37% | 205B | ||
| Average | +2.55% | +1.93% | +41.29% | +73.26% | 417.74B | |
| Weighted average by Cap. | +2.85% | +3.04% | +52.09% | +99.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 147M 132M 122M 110M 206M 14.01B 209M 1.45B 578M 7.33B 552M 540M 23.22B | 916M 137M 123M 114M 103M 192M 13.08B 195M 1.35B 540M 6.85B 516M 505M 21.68B |
| Net income | 60.07M 9.01M 8.07M 7.45M 6.74M 12.6M 858M 12.81M 88.86M 35.45M 449M 33.83M 33.11M 1.42B | 49.21M 7.38M 6.61M 6.1M 5.52M 10.32M 703M 10.49M 72.79M 29.04M 368M 27.71M 27.12M 1.17B |
| Net Debt | -357M -53.58M -47.99M -44.28M -40.07M -74.93M -5.1B -76.14M -528M -211M -2.67B -201M -197M -8.46B | -479M -71.87M -64.38M -59.39M -53.75M -101M -6.84B -102M -709M -283M -3.58B -270M -264M -11.35B |
Employees
1,332
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CN¥7.410 | -0.40% | 3,745,921 |
| 28/10/26 | CN¥7.440 | -1.06% | 4,309,800 |
| 27/10/26 | CN¥7.520 | -2.34% | 3,857,900 |
| 26/10/26 | CN¥7.700 | -0.26% | 3,244,900 |
| 23/10/26 | CN¥7.720 | +0.13% | 4,436,999 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















